Translating Pre-Clinical Research to Clinical Patient Care™


MSACL 2025

Montreal 21-26

Submission Guidelines


PODIUM Deadline :Mar 19, 2025

PODIUM Acceptance Notice:May 31, 2025

POSTER Deadline to receive response before EB Registration deadline:Mar 19, 2025
POSTER Deadline to make program:Jul 17, 2025

ALERT: Continuing Medical Education (CME) Requirements

We are working under CME requirements.

This requires that you DO NOT have ANY logos from ineligible organizations (e.g., commercial organizations) on ANY of the slides. You can include text representations.

You can include logos from eligible organizations, such as universities, government agencies, hospitals (more info here).

You will be required to pre-submit your slides for pre-liminary review by August 20. The FINAL version must be uploaded by September 10. This is the version that will be placed on the presentation computer.

Q: Why are we doing CME?

A: To attract more people who are clinicians and need this level of education credit in order to justify meeting attendance time and cost.

General Guidelines:

  1. You may submit ONE abstract. However, Case Studies, Troubleshooting and Invited Practical Training abstracts DO NOT count against this allowance.

  2. If you submit for a podium and are NOT selected, your abstract will be immediately considered for a poster position.

  3. You must be the presenter of the abstract that you submit.

  4. While presenter substitutions are permitted, they MAY NOT result in any individual presenting more than one abstract.

  5. Following acceptance, in order to become part of the Scientific Program you must purchase a conference registration by the EarlyBird Registration Deadline for Podium Presenters and by the Regular Registration Deadline for Poster presenters.

Abstract Structure Guidelines:

  1. No graphics or tables.
  2. No lists. Must be written in paragraph format.
  3. Abstract body (Structured Abstract) is limited to 6000 characters, including spaces.
  4. What is a Structured Abstract (click here)?
  5. Abstracts must be Structured, unless they are for an invited Plenary / Keynote (in which case they can be free form), or are Troubleshooting (view example) or Clinical Case Studies (view example).
  6. Title:
    Limit to ~25 words (160 characters including spaces).
    You MUST format your title according to the Chicago Style Guide (Use This Tool to Capitalize My Title)
  7. Author(s):
    List ALL authors.
    Example: John Smith (1), Sam Adams (2)
    Use numbers (1, 2, etc) ONLY for multiple affiliations.
    Do NOT use numbers if all authors have the exact same affiliation(s).
  8. Affiliation(s):
    Example: (1) University of California, San Diego, CA (2) Max-Planck-Institut, Munich, Germany

Abstract Topics

MSACL is soliciting abstracts for both oral and poster presentations under the topics of:

  1. Artificial Intelligence
  2. Assays Leveraging Technology
  3. Breath Analysis and VOC
  4. Cases in Clinical Analysis
  5. Cases of Unmet Clinical Needs
  6. Data Analytics
  7. Emerging Technologies
  8. Environmental Sustainability
  9. Glycomics
  10. Identifying High Value Tests
  11. Imaging
  12. Lipidomics
  13. Metabolomics
  14. Microbiology
  15. Multi-omics
  16. Practical Training
  17. Pre-Analytics
  18. Precision Medicine
  19. Proteomics
  20. Tox / TDM / Endocrine
  21. Troubleshooting
  22. Various OTHER

Previously Copyrighted Material is NOT PERMITTED for Presentations
-- unless you are the copyright holder --
If you published in JMSACL, you are the copyright holder

Following submission and confirmation you will be able to Edit or Delete your abstract via your Network Directory Profile.

Introduction to Cases in Clinical Mass Spectrometry :: Podium or Poster


MSACL is inviting clinical cases or case series wherein the use of mass spectrometry to improve the current standard of clinical management of disease states is demonstrated. Attendees of the clinical case track will learn to identify and appreciate how mass spectrometry enhances patient care and guides clinical practice. The clinical case track will feature unique cases in interactive case sessions. Each case will exemplify a teaching pearl in clinical medicine and/or mass spectrometry and underscore the growing relevance of mass spectrometry to clinical medicine.

The clinical case abstract track will highlight cases where the use of mass spectrometry guided or changed the discourse of disease diagnosis and/or management. Abstracts will typically focus on an index case but may also describe a series of cases where the use of mass spectrometry facilitated and improved clinical management. The abstract should be structured with the following headings –Case Description, Background, MS Methods and Results, Discussion and Conclusion. The abstract may contain description of one or more specific cases and describe how mass spectrometry was leveraged to (a) improve current standard of clinical management (b) guide appropriate pharmacotherapy and/or treatment response, (c) identify previously unidentified etiology of disease, (d) diagnose toxicity, (e) differentiate disease states, (f) improve or change clinical outcome(s).

Troubleshooting Forum :: Poster Only


The Troubleshooting Forum has been created to provide a setting for discussion between LC-MSMS users working in clinical diagnostics. If you've had an LC-MSMS problem that has either been resolved with troubleshooting techniques, or is still in the process of resolution - this is an opportunity to share your experience with other clinical laboratory users. The more resolution needed the better. Simple or complex, method development, method validation or production - all types of troubleshooting cases are needed. If you learned something from it, the chances are someone else can learn something as well. The intent is to stimulate discussion and to propagate expertise and solutions on those aspects of the mass spectrometry experience that rarely see daylight ... when everything goes horribly wrong. This is not about being perfect, or even close. Come to learn, or come to share. Or both. One or more Troubleshooting Poster Rounds will be scheduled in which a team of experienced users (and interested attendees) will visit posters to listen to a brief summary by the presenter, and then discuss the case and provide suggestions. If you want your poster to be included in Troubleshooting Poster Rounds, select the Troubleshooting Poster Rounds topic when you submit your abstract.

Troubleshooting Requirements:

(1) Content must be vendor neutral.
(2) There must be a strong point/experience to get across that is also vendor neutral (i.e. would benefit everyone regardless of the platform they use).
(3) No generic troubleshooting (i.e., autosampler problems, pump problems, most commonly encountered problems from the hotline, etc.).

TROUBLESHOOTING BONUS: Troubleshooting Abstracts do not count towards your abstract count. You can submit your own research AND a Troubleshooting abstract.

The Review Process:
All submitted abstracts are reviewed by the Steering Committee for scientific merit and appropriateness of content. Abstracts submitted for a podium presentation, but which are not chosen for an oral presentation will automatically be considered for poster contention.


The presenting author/person assumes full responsibility of the content of the abstract with all co-authors aware of this content. Please note that any material you submit and/or present including, but not limited to, your biography, summary and abstract may be used on the MSACL website and/or in conference materials.